Back to Blog
Key Takeaways
  • Pricing Structure: Losing Weight RX features a flat rate of $146/mo all-inclusive. Noom Med operates on a tiered system starting at $199–$209/mo for low doses and climbing to $279/mo for full clinical doses. LW RX Wins
  • User Experience & Compliance: Noom Med requires active daily participation in food logging, weight tracking, and psychological lessons via their mobile app. Losing Weight RX offers a direct, clinical, and private medical pathway without mandatory gamified daily software tracking. LW RX Wins
  • Yearly Savings: Choosing Losing Weight RX yields an annual cost of $1,752, compared to Noom Med's $2,388–$3,348+. This results in direct savings of $636 to $1,596 per year depending on your clinical dose. LW RX Wins
  • State Availability: Losing Weight RX works with compounding pharmacies licensed in all 50 states. Noom Med's compounded GLP-1 program is restricted to certain states based on their pharmacy network. LW RX Wins
  • Active Ingredients: Both platforms offer access to compounded semaglutide, delivering the same active GLP-1 receptor agonist molecule. Tie

The Quick Verdict

Telehealth weight loss options have grown rapidly in 2026, offering diverse models that blend modern clinical care with digital tracking. Two names that frequently stand out are Losing Weight RX and Noom Med. However, their clinical pathways, billing models, and patient requirements are vastly different. If you are trying to decide which platform fits your budget and lifestyle, the choice depends on how much you value daily digital tracking versus a direct, affordable medical pathway.

Losing Weight RX offers compounded semaglutide for a single flat rate of $146 per month. This price is completely all-inclusive: it covers the medication, your medical assessment by a licensed provider, ongoing support, and expedited shipping. There are no price hikes as your doctor increases your dose, no hidden platform subscriptions, and no cancellation fees.

Noom Med operates on a tiered-pricing, bundled-service structure. While they offer access to compounded semaglutide, the cost is tied directly to your active dose. Low initiation doses start at $199 to $209 per month, but once you titrate up to full clinical maintenance doses, the monthly price rises to $279 per month. Additionally, Noom requires you to actively use their daily tracking mobile application, logging meals, water, steps, and participating in psychological lessons. If you miss days or stop logging, you still pay the monthly membership.

For patients seeking a straightforward, transparent medical program that delivers the identical active GLP-1 molecule without mandatory app compliance or dose-escalation price hikes, Losing Weight RX represents the clear value leader. Over the course of a single year, switching from Noom Med to Losing Weight RX can save you between $636 and $1,596. Let's look closer at the details of how these two programs compare.


Company Overview: Noom Med

Noom originally gained fame in the late 2010s as a mobile-first weight loss app focused heavily on cognitive behavioral therapy (CBT). By categorizing foods into "green, yellow, and orange" groups and requiring users to complete daily psychological lessons, Noom aimed to change how people think about food. The company raised over $650 million in venture funding, transforming into a household brand name in the wellness space.

In 2023, acknowledging the clinical paradigm shift represented by GLP-1 receptor agonists, the company launched Noom Med. This clinical division blends Noom's traditional psychological tracking software with telemedicine access to board-certified physicians, clinical lab work, and prescription weight loss medications, including compounded semaglutide and brand-name GLP-1s.

Noom Med represents a "hybrid" model of care. It assumes that medication alone is not enough to maintain weight loss and that patients must systematically rewrite their lifestyle habits through continuous daily software feedback. Because of this, you cannot separate Noom Med's clinical care from its software ecosystem. The pricing reflects this bundle, requiring patients to pay for both the medical care and the daily application access simultaneously.


Company Overview: Losing Weight RX

Losing Weight RX was established with a singular, contrasting goal: to remove the friction, high costs, and mandatory software tracking associated with modern medical weight loss. By focusing exclusively on GLP-1 telehealth treatments, Losing Weight RX bypasses the need for bloated software suites, excessive platform check-ins, and complex membership tiers.

The company partners with state-licensed, U.S.-accredited compounding pharmacies to deliver compounded semaglutide directly to patients' homes. The process is entirely clinical and streamlined: patients fill out a secure, comprehensive online medical intake; a licensed healthcare provider reviews the assessment within 24 hours; and, if clinically appropriate, the prescription is sent directly to the compounding pharmacy. The medication is prepared, packaged with cold chain protection, and shipped overnight or via expedited courier to the patient's door.

Losing Weight RX operates as an independent, lean medical service. Without massive VC-driven growth targets, the platform can sustain a flat-rate price of $146/mo across all dosages. This makes it highly appealing to self-pay patients, those without insurance coverage for brand-name GLP-1s, or individuals who want direct access to a medical provider without forced daily digital tasks.


Noom Med's Pricing Structure: The Dose Escalation Tax

Pricing transparency is a major talking point in telehealth. While many providers advertise low "starting at" prices, these rates often apply only to the initial, sub-clinical doses of medication. Noom Med uses this tiered structure, which can make long-term financial planning difficult for patients.

1. Tiered Pricing for Compounded Semaglutide

GLP-1 treatments require a titration schedule—meaning patients start on a very low dose to let their body adjust, and slowly increase the dose month-by-month until they reach a stable maintenance level. Noom Med's monthly fees change as you titrate up:

Because the therapeutic doses are where patients spend the majority of their weight loss journey (often 10 months or more of the first year), the real long-term cost of Noom Med is effectively $279 per month, rather than the lower advertised entry rate.

2. First-Month Onboarding and Clinical Fees

In addition to the ongoing monthly rate, Noom Med often requires a first-month clinical fee or application fee ranging from $99 to $129, depending on active promotions. This fee covers the initial evaluation, coordinating laboratory tests (if necessary), and setting up the subscription account. This adds a substantial upfront hurdle before your first vial of compounded semaglutide is even shipped.

3. The Telehealth-Only Pathway

For patients who have insurance coverage that covers brand-name Wegovy, Ozempic, or Zepbound, Noom Med offers a "Telehealth-Only" tier starting at approximately $69 per month. However, this fee only covers the medical provider's time to write the prescription and run prior authorizations. It does not cover the cost of the medication at the retail pharmacy. If your insurance denies coverage, you will be responsible for the full retail cost of the brand-name drug (which frequently exceeds $900 to $1,000 per month out of pocket).


Losing Weight RX's Pricing Structure: A Flat $146 All-Inclusive Rate

Losing Weight RX rejects the tiered model in favor of absolute price simplicity. The program charges a flat $146 per month, regardless of whether you are taking the starting initiation dose or the maximum clinical maintenance dose. The price remains identical from month one through month twelve.

No Hidden Fees or Upgrades

Losing Weight RX has no registration fees, no monthly software membership fees, and no shipping charges. Unlike platforms that charge more for higher doses—which we refer to as a "dose escalation tax"—Losing Weight RX maintains the same $146/mo rate even when your provider increases your dose from 0.25mg to the maximum clinical dose of 2.4mg. You only pay for the medical treatment itself.

Why Flat-Rate Pricing Matters for Titration

To understand why this is a significant advantage, look at the typical titration schedule for compounded semaglutide. A patient starting their journey will follow a timeline similar to this:

Under Noom Med's structure, you will pay the lower $199–$209 rate for the first two months, but by Month 3 and beyond, your cost jumps to $279/mo. Under Losing Weight RX, your price remains fixed at $146/mo, saving you $133 per month once you reach the maximum dose. This predictable cost structure makes it far easier to budget for the full 6-to-12-month program required to reach your target weight.

12-Month Total Cost Projection

Let's map out the total out-of-pocket costs over a 12-month period for both programs, factoring in standard titration schedules and onboarding fees.

Noom Med
Tiered Compounded Semaglutide
$199–$279 /month
Pricing rises as your dose increases. Low starting doses are $199–$209/mo, maintenance doses are $279/mo. Onboarding fees may apply.
12-Month Total: $2,388–$3,348+

Choosing Losing Weight RX over Noom Med saves patients an average of $1,200+ in their first year. That is equivalent to over 8 months of free treatment at the Losing Weight RX flat rate.

Noom Med vs. Losing Weight RX

Get Compounded Semaglutide for a Flat $146/mo

Why pay up to $279/mo for tiered doses and app subscriptions? Access the same active GLP-1 molecule through Losing Weight RX's simple, doctor-supervised medical pathway for a flat monthly rate.

Start Your Assessment
Flat $146/mo (All Doses)
No Mandatory App Tracking
Licensed U.S. Pharmacies

Feature Comparison: App Logging vs. Direct Medical Care

Beyond pricing, the day-to-day user experience of these two platforms is completely different. The decision often comes down to your personal style of accountability and whether you want an app-driven lifestyle program or a traditional, private medical service.

Noom Med's Philosophy: Accountability via App Compliance

Noom Med is built around active digital engagement. When you sign up, you are given access to the Noom mobile application, which serves as your central command hub. Every day, the platform expects you to perform several tasks:

For some patients, this structured, gamified approach is highly effective. It provides a constant reminder of their weight loss goals and helps build long-term dietary habits. However, for many others, forced daily tracking feels tedious, invasive, and exhausting. If you have a busy schedule, logging every meal can quickly become a chore. Additionally, if you fail to log, you may feel guilty, even though you are still paying for the program.

Losing Weight RX's Philosophy: Streamlined Clinical Care

Losing Weight RX approaches weight loss as a medical condition rather than a behavioral game. The platform focuses on delivering high-quality, doctor-supervised clinical treatment without forced software interactions. The experience is designed to be smooth and private:

If you already know how to eat healthy, or if you prefer to track your lifestyle independently (or not at all), Losing Weight RX provides a clean, professional medical pathway that respects your time and independence.


Medication Sourcing: Compounded Semaglutide Safety and Regulations

Because both platforms offer compounded semaglutide, it is important to understand what this medication is, how it is made, and the regulatory environment governing it in 2026.

What is Compounded Semaglutide?

Compounded semaglutide is a custom-formulated medication created by state-licensed compounding pharmacies. It contains the identical active pharmaceutical ingredient (API)—semaglutide—as brand-name Wegovy and Ozempic. Because these brand-name drugs have faced severe nationwide shortages due to high demand, U.S. law allows compounding pharmacies to prepare custom formulations of the molecule to ensure patients can maintain access to their treatments.

It is crucial to understand that compounded semaglutide is not "generic Wegovy." There is no approved generic version of Wegovy. Instead, compounded semaglutide is a legal, customized preparation prepared under federal and state compounding guidelines (specifically Section 503A of the Food, Drug, and Cosmetic Act).

How Sourcing Varies Between the Two Platforms

The safety of compounded medication depends entirely on the compounding pharmacy that prepares it. Both Losing Weight RX and Noom Med use rigorous standards, but there are subtle differences in their pharmacy networks:

Every dose of compounded semaglutide dispensed by both platforms is evaluated for purity, potency, and sterility, ensuring you receive a safe and effective treatment. To learn more about compounding standards, read our detailed guide: Is Compounded Semaglutide Safe?


Side-by-Side Comparison Table

The table below outlines the core differences in pricing, features, requirements, and logistics between Losing Weight RX and Noom Med. For comparisons with other popular telehealth weight loss platforms, read our Cheapest Semaglutide Online in 2026, Losing Weight RX vs. Hims (see Losing Weight RX vs. Found), and Losing Weight RX vs. Henry Meds comparison articles.

Feature / Metric Losing Weight RX Noom Med
Monthly Total Cost $146 (Flat rate, all-inclusive) $199–$279 (Tiered based on dosage)
Dose Escalation Fees None (Same price for all doses) Yes (Price increases at maintenance doses)
12-Month Total Cost $1,752 $2,388–$3,348+ (Includes titration)
Annual Savings $636–$1,596 Saved $0 (Baseline price)
Mandatory App Logging No (Streamlined patient portal check-ins) Yes (Daily meals, weight, steps, and lessons)
Onboarding / Assessment Fees $0 $99–$129 (Varies by clinical promotion)
Medication Sourcing U.S. State-Licensed Compounding Pharmacies U.S. Licensed Compounding & Brand Pharmacies
State Availability All 50 U.S. States Restricted (Not available in all states)
Shipping Fees $0 (Free expedited cold-chain shipping) Included in membership
Provider Consultation Included (Asynchronous, reviewed in 24 hours) Included (Through clinical portal)
Cancellation Policy Cancel anytime via patient portal Cancel subscription via app/website
HSA / FSA Accepted Yes Yes
Swipe horizontally to view comparison details

Who Should Choose Noom Med?

While Losing Weight RX is the clear choice for cost-conscious patients, Noom Med may be a better fit for certain individuals who prioritize daily software-assisted accountability:

Who Should Choose Losing Weight RX?

Losing Weight RX is the ideal provider for patients who want a simple, affordable, and private medical experience:


Frequently Asked Questions (FAQs)

The real monthly cost of Noom Med's compounded semaglutide program ranges from $199 to $279 per month depending on your active dose. Low doses (initiation/microdosing) start around $199 to $209 per month, but as you titrate up to full clinical maintenance doses, the price increases to $279 per month. In addition, Noom often requires a first-month clinical fee or application fee of $99 to $129 depending on current promotional structures.

Losing Weight RX offers a flat rate of $146 per month for compounded semaglutide across all dosage tiers, from initiation to maintenance. Noom Med operates on a tiered pricing system where low doses cost $199–$209 per month and increase to $279 per month for full maintenance doses. This difference results in annual savings of $636 to $1,596 for patients who choose Losing Weight RX.

No. Losing Weight RX provides a streamlined, direct medical pathway. While Noom Med mandates daily psychological tracking, food logging, and behavioral lessons through their proprietary mobile application, Losing Weight RX focuses on clinical care, provider check-ins, and direct medication access. If you prefer a simple medical experience without forced daily software logging, Losing Weight RX is the ideal option.

No. The active ingredient in compounded semaglutide is identical across both platforms. Both platforms source their compounded medications from state-licensed, U.S. compounding pharmacies that synthesize the active GLP-1 receptor agonist molecule. The primary differences lie in the pricing model, mandatory app usage, and state availability rather than the chemical composition of the medication.

Yes. Losing Weight RX operates a robust network of state-licensed compounding pharmacies that allows them to prescribe and ship compounded semaglutide to patients in all 50 U.S. states. This is a significant advantage over other telemedicine platforms, including Noom Med, whose compounding pharmacy networks may have limited geographic licensing coverage.

Yes. Losing Weight RX does not lock you into long-term contracts or annual memberships. You are billed on a simple month-to-month basis, and you can cancel, pause, or change your subscription at any time directly through your patient portal with no cancellation fees or penalties.


Final Recommendation: The Clear Value Leader

Comparing Losing Weight RX and Noom Med reveals two distinct approaches to medical weight loss. Noom Med has built a high-profile, venture-backed program that attempts to combine clinical medication with daily digital behavior tracking. While this comprehensive structure appeals to some, the tiered dosage pricing ($199–$279/mo), onboarding fees, and forced daily app compliance make it expensive and time-consuming for many patients.

Losing Weight RX focuses on clinical efficiency and price simplicity. By offering compounded semaglutide at a flat $146 per month all-inclusive, they remove the dose escalation tax and the hidden subscription fees. The savings are clear: patients save between $636 and $1,596 annually compared to Noom Med's tiered pricing model.

If you want a straightforward, professional medical weight loss program that delivers the same high-quality active GLP-1 molecule without mandatory app tracking, dose escalation surcharges, or geographic restrictions, Losing Weight RX is the clear choice.


Start Your Transformation

Get Semaglutide for $146/mo — No Membership Required

Complete your 5-minute online assessment, get evaluated by a U.S.-licensed provider within 24 hours, and receive your treatment shipped directly to your door. No hidden fees. No contracts. No annual commitment.

Get Started Today
5-Minute Online Intake
U.S. Licensed Providers
Shipped Directly to You

Clinical References & Sources

  1. U.S. Food and Drug Administration. (2024). Human Drug Compounding Under Section 503A of the FD&C Act. FDA.gov Guidance
  2. National Institutes of Health. (2025). Clinical trials database for semaglutide (STEP-1). ClinicalTrials.gov (NCT03548935)
  3. U.S. Food and Drug Administration. (2026). FDA Drug Shortages Database. FDA Shortages Log